Everest Medicines Ltd

Common Name
Everest Medicines
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
722
Ticker
1952
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Everest Medicines Ltd. is a biopharmaceutical company primarily focused on the development and commercialization of transformative pharmaceutical products. Its primary aim is to address critical unmet...

Everest Medicines's Climate Target Data Preview

As of 2024, Everest Medicines has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 intensity-based target, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Everest Medicines ’s climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Intensity-based Target
Scope 1 - Total, Scope 2 - Total, Scope 3 - Total
Metric Tonnes of CO2 equivalent (mtCO2e) per Employee
Copy restricted. Please purchase to unlock this data.
a
2030
Download Everest Medicines's Climate Targets data for free

Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.

Verified Sources Behind Everest Medicines’s Climate Targets Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Everest Medicines’s data sources below and access millions more through our Disclosure Search.

a. Everest Medicines's ESG Report 2024
Trace every data point back to Everest Medicines’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Insights into Everest Medicines's Greenhouse Gas Emissions Pathways

As of 2024, Everest Medicines has set greenhouse gas (GHG) emissions reduction targets that cover only its total carbon footprint, without separate targets for operational (Scope 1 and 2) or value chain (Scope 3) emissions. This limits the ability to track progress across distinct emissions categories. a

Does Everest Medicines have a target to reduce its total carbon footprint?

As of 2024, Everest Medicines has set a target to reduce its total carbon footprint, specifically those from Scope 1, Scope 2 and Scope 3 sources. a

Everest Medicines's most ambitious carbon footprint target is to reduce its scope 1, 2 and 3 emissions from a baseline of 7.41 Metric Tonnes of CO2 equivalent (mtCO2e) per Employee in 2024, by 5% by 2030. a

a

Everest Medicines's Carbon Footprint (Scope 1+2+3) Emissions Pathway

2024203002468Target 2030 (-5%)
Want Full Access to Everest Medicines's Climate Targets Dataset?
Sign Up